PL2301525T3 - Preparat ibuprofenu do stosowania miejscowego - Google Patents

Preparat ibuprofenu do stosowania miejscowego

Info

Publication number
PL2301525T3
PL2301525T3 PL09757648T PL09757648T PL2301525T3 PL 2301525 T3 PL2301525 T3 PL 2301525T3 PL 09757648 T PL09757648 T PL 09757648T PL 09757648 T PL09757648 T PL 09757648T PL 2301525 T3 PL2301525 T3 PL 2301525T3
Authority
PL
Poland
Prior art keywords
ibuprofen
preparation
topical application
topical
application
Prior art date
Application number
PL09757648T
Other languages
English (en)
Inventor
De Blas Andrés Pinilla
Vicente Ana Ortiz
Aguirre Jaime Comín
Ibarra Esther Vayá
Enseñat Pedro González
Original Assignee
Laboratorios Alcala Farma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Alcala Farma S L filed Critical Laboratorios Alcala Farma S L
Publication of PL2301525T3 publication Critical patent/PL2301525T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09757648T 2008-06-06 2009-04-30 Preparat ibuprofenu do stosowania miejscowego PL2301525T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200801720A ES2330295B1 (es) 2008-06-06 2008-06-06 Formulacion topica de ibuprofeno.
EP09757648.2A EP2301525B1 (en) 2008-06-06 2009-04-30 Topical ibuprofen formulation
PCT/ES2009/070131 WO2009147269A1 (es) 2008-06-06 2009-04-30 Formulación tópica de ibuprofeno

Publications (1)

Publication Number Publication Date
PL2301525T3 true PL2301525T3 (pl) 2014-01-31

Family

ID=41338228

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09757648T PL2301525T3 (pl) 2008-06-06 2009-04-30 Preparat ibuprofenu do stosowania miejscowego

Country Status (6)

Country Link
US (1) US20090304782A1 (pl)
EP (1) EP2301525B1 (pl)
ES (1) ES2330295B1 (pl)
PL (1) PL2301525T3 (pl)
PT (1) PT2301525E (pl)
WO (1) WO2009147269A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
CN102579350B (zh) * 2012-03-02 2013-04-24 海南灵康制药有限公司 右旋布洛芬脂质体固体制剂
WO2014144365A1 (en) * 2013-03-15 2014-09-18 University Of Maryland, College Park Nano-liposomal formulations and methods of use
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
CN116370428A (zh) * 2023-04-28 2023-07-04 济南市中西医结合医院 一种布洛芬缓释片、制备方法及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
AU587299B2 (en) * 1985-11-27 1989-08-10 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti- inflammatory drug
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
GB2217596A (en) 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
US5036046A (en) 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
ATE118168T1 (de) 1990-12-03 1995-02-15 Vestar Inc Verhütung der synovialischen adhäsion.
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
EP0648114B1 (de) 1992-07-08 1997-09-17 DIANORM G. Maierhofer GmbH Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
DE19852928C1 (de) * 1998-11-17 2000-08-03 Steffen Panzner Strukturen in Form von Hohlkugeln
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US7132452B2 (en) 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
CA2500907A1 (en) 2005-03-15 2006-09-15 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20060222695A1 (en) * 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation
US20080132751A1 (en) * 2006-11-30 2008-06-05 Betazone Laboratories, Inc. Compositions and methods for treatment of pain

Also Published As

Publication number Publication date
EP2301525B1 (en) 2013-09-11
US20090304782A1 (en) 2009-12-10
EP2301525A1 (en) 2011-03-30
EP2301525A4 (en) 2013-01-16
ES2330295A1 (es) 2009-12-07
WO2009147269A1 (es) 2009-12-10
PT2301525E (pt) 2013-10-16
ES2330295B1 (es) 2010-09-23

Similar Documents

Publication Publication Date Title
PL2301525T3 (pl) Preparat ibuprofenu do stosowania miejscowego
PL2376533T3 (pl) Preparat przeciwciała
EP2504034A4 (en) Topical ibuprofen formulations
PL2379086T3 (pl) Preparat farmeceutyczny
EP2358392A4 (en) ANTIBODY FORMULATION
BRPI0912213A2 (pt) preparação cosmética
EP2248470A4 (en) APPLICATOR
DK2273984T3 (da) Lipidsammensætning
BRPI0918419A2 (pt) nova formulação anticorpo
BRPI0913945A2 (pt) agentes anti-inflamatórios
BRPI0912026A2 (pt) formulação homeopática
EP2331854A4 (en) COMPOSITE WIPES
DK2285413T3 (da) Farmaceutisk sammensætning
EP2236149A4 (en) MEDICAL COMPOSITION
BRPI0914063A2 (pt) composição de xampu concentrado
DOS2008000078S (es) Dispositivos para aplicar betun al calzado
BRPI0921313A2 (pt) composição farmaucêutica
BR112012015447A2 (pt) composição tópica para aplicação cutânea
BRPI0912171A2 (pt) composição farmacêutica
BRPI0921301A2 (pt) composição farmacêutica
HRP20180222T1 (hr) Sastav ropinirola
EP2659889A4 (en) FARROWING / PAINFUL COMPOSITION
BRPI1007164A2 (pt) composição tópica
PL385868A1 (pl) Preparat weterynaryjny
BRPI0906879A2 (pt) Compostos terapêuticos